Launch week offerEnds in00h00m00s

annual Promonthly Pro

Go Makimoto

Assistant Professor

Okayama University

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Articles (7)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (4)

Yin Min Thu

Project Assistant Professor

Okayama University

JAPAN

View details

Mizuo Ando

Professor

Okayama University

JAPAN

View details

Kadoaki Ohashi

Okayama University Hospital

JAPAN

View details

Isao Oze

Unit Leader

Aichi Cancer Center

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Go Makimoto

Research Interests

Make your next move.

Explore related searches

Articles (7)

Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101)

ULK1, a novel therapeutic target to delay drug tolerance to EGFR–TKIs in an EGFR-mutant non-small cell lung cancer model

Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation

Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity

Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report

A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol

Collaborators (4)

Yin Min Thu

Mizuo Ando

Kadoaki Ohashi

Isao Oze

Make your next move.